Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
Background Pancreatic cancer (PC) has much weaker prognosis, which can be divided into diabetes and non-diabetes. PC patients with diabetes mellitus will have more opportunities for physical examination due to diabetes, while pancreatic cancer patients without diabetes tend to have higher risk. Iden...
Main Authors: | Mingjun Yang, Boni Song, Juxiang Liu, Zhitong Bing, Yonggang Wang, Linmiao Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/10297.pdf |
Similar Items
-
Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma
by: Yu Jiang, et al.
Published: (2022-10-01) -
Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics
by: Dongjiao Wang, et al.
Published: (2022-05-01) -
Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer
by: Yuanyuan Zheng, et al.
Published: (2022-05-01) -
Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data
by: Simon Klau, et al.
Published: (2018-09-01) -
A Nomogram for Predicting Patent Foramen Ovale-Related Stroke Recurrence
by: Zhuonan Wu, et al.
Published: (2022-06-01)